Drug screening and grouping by sensitivity with a panel of primary cultured cancer spheroids derived from endometrial cancer

Putative tumor suppression function of SIRT6 in endometrial cancer

(2015) Tomohiko Fukuda et al.   FEBS LETTERS

Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma

(2015) L Zhang et al.   Cell Death & Disease

YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells

(2014) S M Cheng et al.   BRITISH JOURNAL OF PHARMACOLOGY

Trends in corpus uteri cancer mortality in member states of the European Union

(2014) Elisabete Weiderpass et al.   EUROPEAN JOURNAL OF CANCER

Recent and current Phase II clinical trials in endometrial cancer: review of the state of art

(2014) Stephanie Lheureux et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review

(2014) Nader Husseinzadeh et al.   GYNECOLOGIC ONCOLOGY

The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity

(2014) Georg E Winter et al.   Nature Chemical Biology

Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma

(2013) Yu-Fan Wang et al.   APOPTOSIS

Spheroid Culture of Primary Lung Cancer Cells with Neuregulin 1/HER3 Pathway Activation

(2013) Hiroko Endo et al.   Journal of Thoracic Oncology

Involvement of Heregulin/HER3 in the Primary Culture of Human Urothelial Cancer

(2013) Hiroaki Okuyama et al.   JOURNAL OF UROLOGY

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE

Sepantronium Bromide (YM155) induces disruption of the ILF3/p54nrb complex, which is required for survivin expression

(2012) Tomohiro Yamauchi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

mTOR Signaling in Growth Control and Disease

(2012) Mathieu Laplante et al.   CELL

Markers for individualised therapy in endometrial carcinoma

(2012) Helga B Salvesen et al.   LANCET ONCOLOGY

Endometrial Cancer

(2012) Joel I. Sorosky   OBSTETRICS AND GYNECOLOGY

YM155 Induces EGFR Suppression in Pancreatic Cancer Cells

(2012) Young-Soon Na et al.   PLoS One

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy

(2011) Seth A. Wander et al.   JOURNAL OF CLINICAL INVESTIGATION

Emerging therapeutic targets in endometrial cancer

(2011) Konstantin J. Dedes et al.   Nature Reviews Clinical Oncology

Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer

(2011) J. Kondo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Current status of gynecologic cancer in Japan

(2009) Kimio Ushijima   Journal of Gynecologic Oncology

Everolimus

(2009) Michael B. Atkins et al.   NATURE REVIEWS DRUG DISCOVERY

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

(2008) Carsten Bokemeyer et al.   JOURNAL OF CLINICAL ONCOLOGY